Blueprint
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC
FILE NUMBER
0-28666
CUSIP
NUMBER
024600
(Check
One): ☐ Form
10-K ☐ Form 20-F ☐ Form
11-K ☒ Form 10-Q ☐Form 10-D ☐
Form N-SAR
☐
Form N-CSR
For
period ended March 31,
2019
☐
Transition Report on Form 10-K
☐
Transition Report on Form 20-F
☐
Transition Report on Form 11-K
☐
Transition Report on Form 10-Q
☐
Transition Report on Form N-SAR
For the
Transition Period Ended:
Nothing in this form shall be construed to imply that the
Commission has verified any information contained
herein.
If the
notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification
relates: Not
Applicable
PART I - REGISTRANT INFORMATION
American Bio Medica Corporation
Full
name of registrant
Former
Name if Applicable
Address
of Pincipal Eecutive Ofice (Sreet and Number)
Kinderhook, New York
12106
City,
Sate and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the
subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if
appropriate)
(a)
The reasons
described in reasonable detail in Part III of this form could not
be eliminated without unreasonable effort or expense;
(b)
The subject annual
report, semi-annual report, transition report on Form 10-K, Form
20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will
be filed on or before the fifteenth calendar day following the
prescribed due date, or the subject quarterly report on Form 10-Q
or subject distribution report on Form 10-D, or portion thereof,
will be filed on or before the fifth calendar day following the
prescribed due date; and
(c)
The accountant's
statement or other exhibit required by Rule 12b-25(c) has been
attached if applicable.
PART III - NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K,
10-Q, 10-D, N-SAR, N-CSR or the transition report or portion
thereof, could not be filed within the prescribed time period.
(Attach extra Sheets if Needed.)
The
Registrant's Quarterly Report on Form 10-Q for the period ending
March 31, 2019, could not be filed without unreasonable effort or
expense within the prescribed time period because we require
additional time to compile and verify the data required to be
included in the report. The Company expects to file the Form 10-Q
on or before Monday, May 20, 2019, in full compliance with the
rules of the Commission.
PART IV - OTHER INFORMATION
(1)
Name and telephone
number of person to contact in regard to this
notification:
Melissa A.
Waterhouse
|
(518)
|
758-8158
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
(2)
Have all other
periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such
shorter period that the registrant was required to file such
report(s) been filed? If the answer is no, please identity
report(s).
☒
Yes No ☐
(3)
Is it anticipated
that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflected by
the earnings statements to be included in the subject report or
portion thereof?
☐
Yes No ☒
If so,
attach an explanation of the anticipated change, both narratively
and quantitatively, and if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
AMERICAN BIO MEDICA CORPORATION
(Name
of Registrant as Specified in Charter)
Has
caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
|
AMERICAN BIO MEDICA
CORPORATION
|
|
|
|
|
|
Date: May
14,2019
|
By:
|
/s/ Melissa A.
Waterhouse
|
|
|
|
Melissa A.
Waterhouse
|
|
|
|
Chief Executive
Officer/ Principal Financial Officer
|
|